7046 Effectiveness of Carboplatin (C) plus weekly docetaxel (D) as second-line treatment for docetaxel-resistant, hormone-refractory prostate cancer (HRPC)

@inproceedings{Reuter20097046EO,
  title={7046 Effectiveness of Carboplatin (C) plus weekly docetaxel (D) as second-line treatment for docetaxel-resistant, hormone-refractory prostate cancer (HRPC)},
  author={C. Reuter and Michael Archer Richard Morgan and Thomas H. Winkler and Martin Fenner and Arnold Ganser and Viktor Gr{\"u}nwald},
  year={2009}
}

Topics from this paper.

Similar Papers